Background: Having first appeared in Europe, synthetic cannabis emerged as a drug of
Code Act of 1995. Consequently, prior to legislative changes in 2011, products containing these chemicals were legal to supply and possess in all Australian states and territories.
While anecdotal reports of synthetic cannabinoid use in Australia date back to 2005, it was in 2011 that synthetic cannabis emerged as a drug of concern in Australia. Kronic has been the most well-known brand of synthetic cannabis in Australia with various blends produced, including Skunk, Purple Haze, Tropical, Pineapple Express, and Black Label. In April 2011, radio and tabloid newspapers first began reporting on the use of Kronic at Western Australian (WA) mine sites as a means of evading drug testing (Macdonald, 2011) . Media interest Within days, new synthetic cannabis blends appeared that claimed to contain new unscheduled synthetic cannabinoid agonists. For example, Kronic released its ‗Black Label' blend specifically for its WA customers. This is consistent with the experience in the UK (Dargan et al., 2011) and the USA (Shanks, Dahn, Behonick, & Terrell, 2012) where analysis of synthetic cannabis blends available after bans found the presence of a range of new chemicals. De Jager et al. (2012) have reported that blends of Kronic purchased after bans in Australia contained chemicals previously unknown to them that were later revealed via mass spectra to be JWH-022 and AM2201.
Then in August 2011, the media reported on a Perth man with a pre-existing heart condition who had a heart attack. While this event is not something the media would normally report on, the man had allegedly been smoking Kronic Black Label prior to his death (Phillips, 2011) . In a response to this alleged first ‗Kronic-related death', the WA government Consequently, products containing any of these eight cannabinoid agonists were by default illegal in states that had not specifically scheduled these chemicals.
It might be suggested that the Australian legislative response to synthetic cannabis has been reactive and piecemeal rather than evidence-based. Some have suggested that banning each chemical as it emerges is like a dog chasing its own tail (Fattore & Fratta, 2011 ). Other commentators have described this approach to legislation as a merry-go-round-as one new drug gets discovered and banned, another one emerges purporting to be ‗legal ' (Dargan et al., 2011; Evans-Brown, Bellis, & McVeigh, 2011; Measham, Moore, Newcombe, & Welch, 2010) . So why has Australia's legislative response to synthetic cannabis not been evidencebased?
It is possible that media reports concerning synthetic cannabis created a moral panic that contributed to a legislative reaction. Early descriptions of moral panic, such as Cohen's (1972) analysis of -Mods‖ and -Rockers‖ in the UK, have noted that moral panic first involves a person, group, episode, or situation being framed by the media as a threat to society. Sometimes the moral panic quickly dissipates, while other moral panics reach critical mass with significant and long lasting repercussions, such as changes in policy. In this respect, Brosius and Weimann (1996) have suggested that the media sets the agenda for policy debate.
McArthur (1999, p. 151) has stated that the media -shape[s] not only the public profile of
[drug] problems but also the political response to them‖. Forsyth (2012) has proposed that once media reports concerning the emergence of a new drug break in the mainstream press, they will draw on the ‗drug scare' narrative that constructs the new drug as dangerous and the need for urgent action. In turn, a media campaign against the drug develops that recruits politicians, researchers and the morally righteous. The subsequent moral panic leads to a perception that urgent legislative action is required and is likely to result in policy that is reactive rather than responsive.
Moral panic occurs within the context of the dominant discourses that exist within a society.
For example, Cohen (1972) stated that -by thrusting certain moral directives into the universe of discourse‖ the media can create drug problems -suddenly and dramatically‖ (p. 10). Dominant discourses are linguistic frameworks inherent to any given culture that develop in symbiotic relationships with those institutions with power (Burr, 2003) . They constrain what can be rationally said, written, and thought about drugs. Each discourse provides specific subject positions that demarcate the narratives that are coherent within the discourse (Burr, 2003) . These narratives, such as the ‗drug scare narrative', are perceived by individuals within the culture from which the dominant discourse emanates to hold the most ‗truth' value. Nonetheless, there are competing dominant discourses with some being more privileged than others, and it is in the interest of any given institution to promote those discourses that maintain the institution's version of reality as ‗truth' since this provides the institution with power.
Bright, Marsh, Bishop and Smith (2008) undertook an analysis of the dominant discourses within Australia that frame Alcohol and Other Drugs (AOD). They examined newspaper reports of AOD over a 12 month period, and then triangulated this analysis with a sample of newspaper reports from five years prior and a televised debate on AOD. Bright et al. (2008) determined that in Australia, six dominant discourses framed AOD-related issues: medical, moral, legal, political, economic, and glamour (see Table 1 ). Within medical discourse, for example, drug use is often pathologised such that drug users are sick. This limits the degree to which ‗recreational drug use' can be considered since any drug use is defined as inherently unhealthy. Within this discourse, experts are afforded a subject position that has significant authority and typically support the pathogenic narrative. Further, since medical discourse is paternal, the pathogenic narrative supports prohibition-based drug policy.
[Insert Table 1 about here]
The methodology used by Bright et al. (2008) might not be appropriate for understanding the discourses that framed the emergence of synthetic cannabis in Australia given its rapid emergence and the subsequent constant flux. Rather, methodologies that have explored the rapid emergence of new drugs might have more utility. In this journal, Forsyth (2012) has recently described the phenomena of the ‗drug scare' using the UK experience with Mephedrone as a case study. He proposed that media reports about the emergence of a new drug that are fuelled by ‗moral panic' are unhelpful since they might divert attention from other more significant public health concerns (e.g., alcohol, diabetes, cardiovascular disease, cancer, etc.), and also provide free advertising through creating increased public awareness of the drug. Through examining online media, Forsyth was able to demonstrate that interest in buying mephedrone increased following sensationalist media coverage.
The present study draws from Forsyth's (2012) methodology using Australian online media and self-reports from a sample of Australian synthetic cannabis users to understand how synthetic cannabis emerged as a drug of concern in 2011. In doing so, we aim to explore how the media, legislative change, and drug-related harm intersect. Discursive analysis was used to help disentangle this complex intersection. Such analysis is particularly useful here given the dynamic and rapid social changes that occurred in 2011, since it allows for subjective interpretations of the available anecdotal evidence given limited empirical data.
Method
Drawing from Forsyth's (2012) methodology, Google Trends was first used to produce timetrend graphs detailing the number of stories being published online about synthetic cannabis and Kronic, and also the amount of traffic searching for these terms. Google Trends also generates links to media reports at key milestones. Forsyth has noted some limitations in using this application since Google is not the only search engine; however, it is the most widely used. Further, Google Trends are normalised so the graphs do not represent the absolute number of searches conducted or the number of media stories. Additionally, the media volume reported is dependent on the parameters that Google uses to determine if text is a ‗news story'.
It is reasonable to assume that the ways in which the Australian online media was able to frame the emergence of synthetic cannabis was limited by the available dominant discourses.
As such, the discourse and narratives were examined within the key reports generated by Google Trends. This examination was conducted by the first author (SB). It was iterative and involved consideration of the various subject positions that were available within the text, in addition to the way in which synthetic cannabis was constructed. As each discourse emerged, it was considered within the context of the institutions that support and maintain the discourse. Finally, the discourse was considered within the context of Bright et al. 's (2008) delineation of the dominant discourses available for AODs in Australia.
To ensure credibility (Lietz, 2010) , the data were triangulated with radio media. Two . Purposeful sampling of media reports and social media was also conducted to reconstruct a timeline of the emergence of, and response to, synthetic cannabis. In addition, thick descriptions were provided of each text that used direct quotes to ensure that the analysis stayed true to the original text.
Rigour was ensured through an audit trail that documented the analysis and the reasoning that underpinned the emergent discourses (Morse, 1994) . Thoughtful consideration of the discursive researcher's (SB) standpoint and opinions was documented in the audit trail to ensure reflexivity. This can be summarised in the following disclosure statement:
I dislike paternalism since I value freedom of choice and believe that drug users can rationally weigh up the pros and cons of drug use in the context of the available evidence regarding harm. I believe that drug policy is rarely developed in the context of the available evidence and is often reactive in nature.
By including this statement, we acknowledge that it is impossible for the researcher to be ‗objective' or ‗neutral' in the production of knowledge. Subjectivity, while once seen as negative or as bias to be eliminated, can be used as a fruitful path to greater understanding of the subject matter and our role in its construction. Instead, readers should interpret our paper with knowledge of the discursive researcher's positioning as stated above.
Finally, two pieces of previously-unpublished data were included in this paper from a study by the final author and colleagues (Barratt, Cakic & Lenton, in press): (a) month and year of first use of synthetic cannabis, and (b) where synthetic cannabis users first reported hearing about the drug. A purposive sample of 316 Australian synthetic cannabis users answered these questions as part of an online survey. A description of the sample and the survey methodology has been published elsewhere (Barratt et al., in press ).
Findings and Discussion
Figures 1 and 2 contain graphs produced using Google Trend. The lower line in each figure depicts the volume of media stories being published online that referred to Kronic and synthetic cannabis respectively. The upper line in each figure indicates how many people were searching for -Kronic‖ and -synthetic cannabis‖. As can be seen in Figures 1 and 2 , the first online media stories about synthetic cannabis and Kronic began to emerge in March, with a sharp increase in the number of stories in May and June.
The first key story concerning Kronic was from The Age on June 8 (indicated by ‗A' in Figure 1 ) and was entitled -Roadtesting Kronic: Is fake grass worth the hype?‖. This ‗gonzo journalism' piece describes the author's experience of smoking Kronic and is framed within neo-liberal and economic discourse. For example, the author states that -so many people were having fun with [Kronic] that the anti-fun brigade had no choice but to swing into action‖ and compared the effects of Kronic to -two glasses of champagne‖. Bright et al. (2008) note that within the dominant Australian discursive landscape, only alcohol, tobacco, and caffeine can typically be framed within economic discourse, which means that this story is framed outside of the dominant discourses. Again, use of Kronic was framed within neo-liberal and economic discourse. For example, interviewees stated how they made an informed choice to use Kronic in which the harms associated with failing a drug test outweighed the unknown harms associated with using chemicals with little to no toxicology data. Further, they described responsible use of Kronic, such as not using it before or during work, which also falls outside of the dominant discourses.
Such initial framing was possible without widespread concern regarding synthetic cannabis and is consistent with Forsyth's (2012, p. 198) observation that initial reports regarding a new drug are generally published in alternative publications such as music press (e.g., Triple J Radio) -or equivalent specialist sections of mainstream titles‖ (e.g., The Age). For example, in the UK a report preceding the moral panic regarding Mephedrone appeared in the Telegraph by a prominent medical personality entitled -I took Mephedrone and I liked it‖ (Pemberton, 2010) . Despite being situated outside of the dominant discursive frameworks, such early stories increase the public's awareness and might provide an advertisement for the emergent drug. Indeed, as can be seen from the upper line in Figure 1 , the number of Australian's searching for Kronic on Google began increasing significantly around this time.
It is interesting to note that -Kronic‖ was more searched than -synthetic cannabis‖, perhaps highlighting the effect that the media had on ‗branding' synthetic cannabis. This is similar to the way in which MDMA was branded as Ecstasy in the early 1980's, perhaps since the latter term created additional public interest and may have contributed to the moral panic that precipitated the prohibition of MDMA in the USA (Eisner, 1989).
The increased awareness also provides an impetus for a ‗moral panic', with subsequent stories framed within the dominant discourses. The second key story concerning Kronic was published by the Sydney Morning Herald on 16 June and was entitled -WA becomes first state with Kronic ban‖ (see -B‖ in Figure 1) . Interestingly, the first and only relevant key story concerning synthetic cannabis was also about legislative change -this time the South Australian government's intention to ban synthetic cannabis (see -A‖ in Figure 2 ). Both stories were framed within dominant discourses. Specifically, they were framed within legal, medical and moral discourse.
Within medical discourse synthetic cannabis was constructed as a pathogen with similar (or greater) dangers to cannabis. Such constructions were typically reinforced by experts attesting to these dangers. Within this discursive framework, primacy is given to those individuals assuming the subject position of expert. This subject position is highly regarded in contemporary society, and might be considered to have subsumed the role of the priest as the figure of authority. Like the priest, the information provided by a medical expert is not necessarily ‗true' despite it being perceived as holding the greatest ‗truth' value. Indeed, there are often little to no toxicity data for most emergent drugs. For example, Forsyth (2012) noted that it was the news of a Mephedrone-related death that was later found to be false, which provided the impetus for the UK government to refer the matter to the Advisory Council on the Misuse of Drugs.
Similarly, the second ABC radio show that aired in July focused on the national legislative changes. Here, the federal secretary for health assumed the subject position of expert. From this position she was able to authoritatively declare that synthetic cannabis is -just not safe‖, causing hallucinations and heart palpitations. While there have been increasing reports of synthetic cannabis harms, a recent survey of 316 Australian community-based synthetic cannabis users found that while such effects were reported by around one third of the sample, very few respondents reported that their symptoms were serious enough to seek help and many respondents did not report experiencing these harms (Barratt et al., in press). Barratt et al.'s (in press) survey results also indicate that a desire to use a legal recreational drug was one of the main reasons for first trying synthetic cannabis. Consistent with medical discourse, there was no available subject position for recreational drug users with the secretary stating that there -is no therapeutic reason to be using [synthetic cannabinoid agonists] and that's why they've been banned‖.
Within moral discourse, users assume the subject position of an irresponsible deviant. For example, the South Australian Attorney-General expressed a concern that -users are driving under the influence, posing a serious danger to themselves and others‖. Such constructions, alongside the pathogenic narrative available within medical discourse, indicate a need for urgent legislative intervention. In turn, these discourses provided a fertile environment for ‗moral panic'. This moral panic is likely to have contributed to the first wave of bans that occurred in June and July of 2011 since Australian governments had a moral imperative to take urgent legislative action. Such urgent action was naturally reactive and led to a number of bans placed on individual synthetic cannabinoid agonists. Although authorities may be wellintentioned as they prohibit emerging drugs like synthetic cannabinoid agonists, the unintended consequences of these policies may have increased harm to some users since the reporting of each scheduling decision creates increased awareness. Such increased awareness could lead to increased use of synthetic cannabis.
Indeed, as can seen be from the lower lines in Figures 1 and 2 , online media interest first increased in the lead up to the first wave of bans in June and July. There was also an increase in the number of Australians searching for -Kronic‖ and -synthetic cannabis‖, as indicated by the lower lines in Figures 1 and 2 , which tracks in relative accordance with the increased volume in media. It is reasonable to assume that many of these individuals would not have previously been aware of synthetic cannabis. The first hit for a Google search for ‗Kronic to be banned' that we conducted in June was an Australian-based online Kronic shop, and Google advertisements at the end of many commercial online media reports were for online shops selling synthetic cannabis. Kronic could not have asked for better advertising. Just days after the WA government banned seven synthetic cannabinoid agonists, new products were released that claimed to circumvent the legislative changes. One such product was Kronic -Black Label‖. The final key Kronic-related story, which was published on August 5 in The Australian, described how a man who was -believed‖ to have been smoking Kronic -Black Label-was rushed to hospital after -suffering a suspected heart attack‖. He later died. Entitled -WA police query banned drug Kronic link to man's death‖, this story was framed within medical and legal discourse. Again, the potential harms associated with
Kronic indicated an urgent need for legislative intervention. In response to this death, the WA government banned an additional 14 cannabinoid agonists (Poisons (Appendix A Amendment) Order (No. 2) 2011, Western Australia). Again, media interest and internet traffic searching for -Kronic‖ and -synthetic cannabis‖ increased in the lead up to these bans, as can be seen in Figure 1 and 2.
Conclusions
By examining the emergence of synthetic cannabis as a drug of concern in Australia, the present paper aimed to help understand how the media, legislative change, and drug-related harm intersect. The notion of dominant discourses was proposed to be helpful in understanding this relationship since they will demarcate how the media constructs the emergence of a new drug, how policy makers are able to frame the debate, and in turn, people's drug using behaviour. Evidence-based policy development must consider a psychoactive substance within the complex interrelationships between state and federal legislation, media reporting and dynamic webs of supply and demand. The unpredicted and unintended outcomes of drug policy typically result from inadequete consideration of these factors. For example, workplace drug testing is a well-intentioned policy that aims to reduce drug-related harm, but has had the unintended effect of producing a market for synthetic cannabis as a substitute for cannabis which, until recently, was unable to be detected by workplace drug testing technologies.
However, it is unlikely that Australia's response to synthetic cannabis will consider alternative models of regulation. In May 2012, eight broad chemical groups were scheduled by the TGA: Benzoylindoles, Cyclohexylphenols, Dibenzopyrans, Naphthoylindoles, Naphthylmethylindoles, Naphthoylpyrroles, Naphthylmethylindenes, and
Phenylacetylindoles (TGA, 2012) . In addition, they scheduled -synthetic cannabinomimetics‖, though no definition of this term has been provided. Only time will tell what effects (both intended and unintended) this latest legislative actions will have on drugrelated harm. Note: As Google Trends does not provide raw data, the volume of media reports is only an approximation. Further, the data is normalised and does not represent the absolute number of media stories.
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